Page last updated: 2024-11-03

propranolol and Graft vs Host Disease

propranolol has been researched along with Graft vs Host Disease in 1 studies

Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.

Graft vs Host Disease: The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kidambi, AD1
Mathew, B1
Goodfield, M1
Laws, PM1

Other Studies

1 other study available for propranolol and Graft vs Host Disease

ArticleYear
Sustained response of graft-versus-host disease-associated angiomatosis treated with propranolol.
    Clinical and experimental dermatology, 2018, Volume: 43, Issue:8

    Topics: Adrenergic beta-Antagonists; Angiomatosis; Female; Graft vs Host Disease; Humans; Middle Aged; Propr

2018